NGM BIOPHARMACEUTICALS INC's ticker is and the CUSIP is 62921N905. A total of 3 filers reported holding NGM BIOPHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
| Q2 2023 | $1 | -50.0% | 500 | -28.6% | 0.00% | – |
| Q1 2023 | $2 | -99.2% | 700 | -98.6% | 0.00% | – |
| Q4 2022 | $251 | -100.0% | 50,000 | +15.2% | 0.00% | -100.0% |
| Q3 2022 | $567,000 | +7.4% | 43,400 | +5.3% | 0.00% | 0.0% |
| Q2 2022 | $528,000 | +1289.5% | 41,200 | +1548.0% | 0.00% | – |
| Q1 2022 | $38,000 | -91.1% | 2,500 | -89.6% | 0.00% | – |
| Q4 2021 | $425,000 | +989.7% | 24,000 | +1163.2% | 0.00% | – |
| Q3 2021 | $39,000 | +457.1% | 1,900 | +375.0% | 0.00% | – |
| Q2 2021 | $7,000 | +600.0% | 400 | +39900.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 9,200 | $163,000 | 0.00% |
| SIMPLEX TRADING, LLC | 24,000 | $425,000 | 0.00% |